Literature DB >> 12034456

Evidence for CRK3 participation in the cell division cycle of Trypanosoma cruzi.

María I Santori1, Sebastián Laría, Eliana B Gómez, Ingrid Espinosa, Norbel Galanti, María T Téllez-Iñón.   

Abstract

Trypanosoma cruzi CRK3 gene encodes a Cdc2p related protein kinase (CRK). To establish if it has a role in the regulation of the parasite cell cycle we studied CRK3 expression and activity throughout three life cycle stages. CRK3 from epimastigote soluble extracts interacted with p13(suc1)-beads. Endogenous CRK3 phosphorylated histone H1 and this activity was inhibited by specific CDK inhibitors: Olomoucine, Flavopiridol and Roscovitine. Flavopiridol partially inhibited the growth of T. cruzi epimastigotes at 50 nM, the lowest concentration used, but even with the highest (5 microM), cell growth was not completely arrested. CRK3 from Flavopiridol-inhibited epimastigote extracts exhibited a dose dependent inhibition of histone H1 phosphorylation. T. cruzi p13(suc1)-binding CRK displayed the same inhibition profile. This suggests that CRK3 is the enzyme responsible for the majority of the kinase activity associated with p13(suc1). CRK3 activity of hydroxyurea (HU) synchronized epimastigotes peaked in G2/M boundary while the kinase activity associated to p13(suc1)-beads increased at the same time point but remained high until late G2/M. In addition, CRK3 expression was constant during the cell cycle. This is a common pattern of CDK activity regulation. Taken together, these results support the idea that CRK3 is involved in control of the cell cycle in T. cruzi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034456     DOI: 10.1016/s0166-6851(02)00039-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  7 in total

1.  Regulation of a Myb transcription factor by cyclin-dependent kinase 2 in Giardia lamblia.

Authors:  Chao-Cheng Cho; Li-Hsin Su; Yu-Chang Huang; Yu-Jiao Pan; Chin-Hung Sun
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  Colchicine treatment reversibly blocks cytokinesis but not mitosis in Trypanosoma cruzi epimastigotes.

Authors:  Mariana Potenza; María Teresa Tellez-Iñón
Journal:  Parasitol Res       Date:  2014-11-20       Impact factor: 2.289

Review 3.  Protein kinases as drug targets in trypanosomes and Leishmania.

Authors:  Christina Naula; Marilyn Parsons; Jeremy C Mottram
Journal:  Biochim Biophys Acta       Date:  2005-09-08

4.  Histone H1 of Trypanosoma cruzi is concentrated in the nucleolus region and disperses upon phosphorylation during progression to mitosis.

Authors:  Luciana M Gutiyama; Julia P Chagas da Cunha; Sergio Schenkman
Journal:  Eukaryot Cell       Date:  2008-02-15

5.  Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.

Authors:  Zhenhua Guo; John W Stiller
Journal:  BMC Genomics       Date:  2004-09-20       Impact factor: 3.969

6.  Transcriptome-wide analysis of the Trypanosoma cruzi proliferative cycle identifies the periodically expressed mRNAs and their multiple levels of control.

Authors:  Santiago Chávez; Guillermo Eastman; Pablo Smircich; Lorena Lourdes Becco; Carolina Oliveira-Rizzo; Rafael Fort; Mariana Potenza; Beatriz Garat; José Roberto Sotelo-Silveira; María Ana Duhagon
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

7.  EmCyclinD-EmCDK4/6 complex is involved in the host EGF-mediated proliferation of Echinococcus multilocularis germinative cells via the EGFR-ERK pathway.

Authors:  Chonglv Feng; Zhe Cheng; Zhijian Xu; Ye Tian; Huimin Tian; Fan Liu; Damin Luo; Yanhai Wang
Journal:  Front Microbiol       Date:  2022-08-04       Impact factor: 6.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.